PMID int64 27.8M 36.2M | Title/Abstract stringlengths 7 10.7k | MeshTerms stringlengths 7 104 | SemanticTypes stringlengths 4 84 |
|---|---|---|---|
34,672,275 | inappropri use topic corticosteroid dermatolog outpati topic corticosteroid group drug anti ammatori immuno suppress anti prolif vasoconstrict effect among common prescrib medic import efficaci manag various dermatolog disord strict implement exist regul need hour prevent widespread abus aim studi investig usag topic corticosteroid therapi recip doctor without | D003880;D010045 | T091;T101 |
34,672,274 | self massag low level laser treatment masset myalgia short term effect aim studi explor effici massag treatment masset myalgia compar biostimulatori laser | D008406;D063806 | T023;T184 |
34,672,273 | associ durat dialysi helicobact pylori infect dialysi patient univers clinic hospit mostar associ helicobact pylori hp infect length dialysi dialysi patient contradictori studi conduct order determin associ durat dialysi hp infect status dialysi patient furthemor biochem paramet monitor two subject group includ studi | D016481;D016480 | T007;T047 |
34,672,272 | preval associ factor antenat anxieti symptom bangladesh repeat measur cluster data analysi antenat anxieti affect mother child spontan abort preeclampsia preterm birth low birth weight common consequ bangladesh limit understand burden antenat anxieti associ factor conduct prospect longitudin studi estim preval anxieti symptom identifi associ factor pregnant women | D011248;D047928 | T046 |
34,672,271 | impact hypoglycemia epa dha supplement brain deriv neurotroph factor level pregnant women type diabet prospect cohort studi addit neuroprotect effect brain deriv neurotroph factor bdnf also play role glucos lipid metabol studi aim find chang bdnf concentr pregnanc type diabet b prove effect dha epa supplement chang bdnf concentr c investig impact hypoglycemia bdnf concentr | D003922;D007003 | T047 |
34,672,270 | signific interleukin tumor necrosi factor alpha level cognit impair among first ever acut ischaem stroke patient acut ischem stroke ai frequent result develop cognit impair quit often persist pathophysiolog mechan involv develop cognit impair partial elucid aim studi evalu correl interleukin il tumor necrosi factor alpha tnf serum level cognit impair ai patient | D002545;D060825;D000083242;D020521 | T048;T047;T046 |
34,672,269 | preval gestat diabet mellitus perinat outcom accord old criteria iadpsg criteria gestat diabet mellitus gdm common metabol disord pregnanc pregnanc gdm wors outcom compar pregnanc normal glucos toler object studi determin preval gdm perinat outcom accord old criteria iadpsg criteria | D016640 | T047 |
34,672,268 | function dysfunct impuls sensat seek medic staff import studi impuls sensat seek medic staff might shed light effect decis make process perform respons aim studi specifi function impuls prevail medic staff compar dysfunct impuls strong relationship function dysfunct impuls sensat seek furthermor aim differenti function dysfunct impuls accord size place medic care practis | D007175;D012309 | T048;T055 |
34,672,267 | attitud toward psychiatri among medic student worldwid review mental disord frequent nowaday consid ie europ number patient doubl time constant declin interest among student choos psychiatri specialti therefor prone investig identifi factor lead low interest psychiatri compar influenc clinic clerkship among medic student worldwid sinc longer local issu also global challeng pubm data base use sourc medic literatur afterward filter establish criteria select elig articl deal attitud toward psychiatri among medic student find indic likelihood select psychiatri career high influenc student percept specialti turn shape mani factor far sever studi underlin import clinic clerkship posit effect among student choos psychiatri specialti high negat opinion among medic student toward psychiatri career choic complet practic necessarili lead chang attitud among differ popul consist previous studi find confirm domin negat opinion among medic student consid psychiatri career | D002982;D011570;D013337 | T097;T065;T091 |
34,672,266 | consequ stress academ fratern meta analyt review modern lifestyl dynam environ progress induc stress among wide rang individu like student healthcar profession banker engin businessmen administr teacher vitriol human psychiatr disord put academ fratern shabbi state | D001523;D013315 | T048 |
34,672,265 | spontan multipl cutan mix tumor japanes giant salamand andria japonicus examin cutan mix tumor wild captur japanes giant salamand andria japonicus tumor either alreadi present andor increas size newli occur capat sampl tumor anim verrucos protrus unaffect anim control examin patholog virolog tumor mm cm size papillari protrus pendul skin surfac cut surfac tumor white lobul partial hard contain mucus tumor present similar histolog characterist hyalin structur exhibit biphas prolifer neoplast epitheli cell partial compos pseudo ductal structur stain posit cytokeratin aeae vimentin b posit blast like mesenchym cell prolifer fill gap epitheli compon transit uniqu mucous gland neoplast tissu observ hyalin structur stain blue azan stain alcian blue period acid schiff pas doubl stain toluidin blue tb stain ph unstain tb ph valu mucus neoplast tissu mucous gland verrucos protrus stain blue alcian blue pas doubl stain tb stain ph reveal metachromasi virus detect tumor tumor diagnos cutan mix tumor confirm neoplast cell origin mucous gland dermi biolog behavior patholog develop tumor elucid tumor potenti negat affect japonicus | D012867;D012878 | T191;T022 |
34,672,264 | spatial cross season pattern coral diseas reef taiwan high preval region variat although research coral diseas increas worldwid remain limit taiwan taiwan locat tropic cancer contain tropic subtrop reef conduct spatial cross season survey taiwan identifi type diseas nondiseas lesion potenti factor influenc coral health overal mean preval diseas nondiseas lesion vari consider across reef region host suscept differ among coral taxa overal mean preval diseas nondiseas lesion highest kent mean sem lowest southern island although preval diseas differ signific season cyanobacteria relat diseas includ black band diseas bbd bbd like syndrom cyanobacteri syndrom slight preval autumn spring furthermor potenti factor influenc coral health ie turf alga bioerod spong coral bleach strong predictor diseas nondiseas lesion preval result advanc understand coral diseas ecolog taiwan highlight need research correl diseas host environ | D037421;D000458 | T204;T007 |
34,672,263 | epizootiolog cryptococcus gattii outbreak porpois dolphin salish sea cryptococcus gattii fungal pathogen primarili affect respiratori nervous system human anim c gattii emerg temper north america multispeci outbreak cryptococcosi british columbia canada washington state oregon usa affect human domest anim wildlif describ c gattii epizoot odontocet case c gattii identifi odontocet washington british columbia speci affect includ harbor porpois phocoena phocoena n dall porpois phocoenoid dalli n pacif white side dolphin lagenorhynchus obliquiden n probabl index case identifi adult male dall porpois yr prior initi terrestri outbreak spatiotempor extent c gattii epizoot defin case odontocet found cluster around terrestri c gattii hotspot case control analys strand uninfect odontocet reveal risk factor infect speci dall porpois age class adult anim season winter studi suggest mycos emerg sourc mortal odontocet outbreak may associ anthropogen environment disturb | D056285;D004289;D050741 | T004;T015 |
34,672,261 | corifollitropin alpha clomiphen citrat dydrogesteron without daili gonadotrophin new option friend protocol high respond oocyt donor compar number oocyt obtain follicular punctur high respond oocyt donor submit ovarian stimul vitro fertil ivf two differ protocol friend convent | D004394;D007247 | T047;T121;T109;T046;T125;T033 |
34,672,258 | ciliari hedgehog signal regul cell surviv build facial midlin craniofaci defect among common phenotyp caus ciliopathi yet development molecular etiolog defect poor understood investig multipl mous model human ciliopathi includ tctn ccda tmem mutant discov display hypotelor narrow midfac earli develop end gastrul tctn mutant display reduc activ hedgehog hh pathway prechord plate head organ prechord plate defect preced reduct hh pathway activ shh express adjac neurectoderm concomit reduct hh pathway activ tctn mutant exhibit increas cell death neurectoderm facial ectoderm culmin collaps facial midlin enhanc hh signal decreas gene dosag negat regul pathway ptch decreas cell death rescu midfac defect tctn ccda mutant result reveal ciliari hh signal mediat communic prechord plate neurectoderm provid cellular surviv cue essenti develop facial midlin | D002470 | T043 |
34,672,257 | cerebellar liponeurocytoma elder patient dna methyl profil help diagnost tool cerebellar liponeurocytoma rare primari cerebellar neoplasm most occur adult howev rare elder | D002528;D018306 | T191 |
34,672,256 | efficaci immunohistochemistri diagnosi molecular genet alter central nervous system glioma next generat sequenc mutat patient identif molecular genet alter becom import part diagnosi care patient brain tumor comparison immunohistochemistri ihc dna sequenc techniqu suggest ihc use identifi surrog mutat glioma howev studi efficaci relat aim compar ihc neuropatholog laboratori commerci avail next generat sequenc ngs platform tempus xt studi immunohistochem stain section glioma identifi mutat isocitr dehydrogenas idh p braf thalassemiament retard syndrom x link protein atrx histon h tempus xt ngs confirm ihc diagnosi idhrh patient brafv patient hkm patient p ngs confirm ihc diagnosi mutat patient patient ihc interpret wild type ngs indic mutat ngs confirm ihc diagnosi atrx mutat patient patient ihc predict mutat confirm ngs anoth ihc predict wild type ngs show mutant patient ihc diagnosi atrx mutat equivoc mutant wild type ngs singl center studi suggest ihc idhrh brafv hkm high reliabl may use confid clinic practic ihc p atrx mutat often reliabl possibl problemat genet studi may necessari determin astrocyt oligodendrogli differenti | D001932;D005910 | T191 |
34,672,255 | sever drug induc immun hemolyt anemia due cefmetazol case report report case drug induc immun hemolyt anemia diiha suspect caus cefmetazol | D000743;D000744;D004364 | T047;T121 |
34,672,254 | bioequival studi two formul terazosin hydrochlorid capsul healthi chines subject fast fed condit studi conduct assess pharmacokinet safeti profil new oral formul terazosin hydrochlorid capsul compar brand name drug | D005215;D053719 | T033;T063;T055 |
34,672,252 | mental health treatment among adult unit state adult receiv mental health treatment past month includ taken prescript medic mental health receiv counsel therapi mental health profession recent studi show symptom anxieti depress among adult increas report describ percentag us adult taken prescript medic mental health receiv counsel therapi mental health profession past month select characterist base data nation health interview survey nhis estim also present mental health treatment defin taken medic mental health receiv counsel therapi past month | D001007;D008603 | T048;T184;T041 |
34,672,251 | perceiv social emot support among adult unit state juli decemb social emot support posit associ improv wellb reduc risk prematur mortal frequenc adult receiv social emot support need vari demograph impact time stress report describ percent distribut perceiv social emot support among adult age percentag adult alway usual support vari select sociodemograph characterist base data nation health interview survey nhis collect juli decemb | D012944 | T054 |
34,672,249 | preclin medic school curriculum firearm violenc develop patient counsel foundat health polici skill firearm violenc uniqu public health crisi usa us major us physician believ discuss firearm safeti patient howev littl educ firearm injuri prevent counsel exist medic school sought address gap creat curriculum firearm violenc part requir preclin medic school cours focus health polici issu | D005389;D014948 | T037;T073 |
34,672,248 | microrna p play role osteogen mct e cell differenti target pdcd program cell death via wnt catenin depend signal pathway osteoporosi defin bone condit character bone mass reduct bone micro architectur qualiti deterior lead compromis strength increas chanc fractur evid shown essenti role microrna mirna various osteogen differenti process howev function mir p differenti osteogen cell possibl mechan remain unclear present studi explor express mir p human osteoporosi specimen osteogen differenti mct e cell function mir p determin use mir p mimic inhibitor luciferas assay use verifi bind mir p pdcd utr alizarin red stain ar alkalin phosphatas alp activ use determin mir p role osteogen differenti final wnt pathway inhibitor use determin mir ppdcdwnt signal pathway regul osteogen differenti found mir p express increas human osteoporosi specimen differenti mct e cell pdcd also identifi target mir p found involv osteogen differenti mir p mimic attenu effect pdcd overexpress final use xav wnt pathway inhibitor downregul osteogen differenti mir appdcdwnt depend signal pathway conclus mir p induc differenti osteoblast miner modul osteoblast differenti factor main osx alp ocn runx inhibit pdcd wnt signal pathway studi provid modal futur use mir p treatment prevent osteoporosi | D015854 | T044 |
34,672,247 | singl center analysi patient extranod margin zone lymphoma breast breast extranod margin zone lymphoma emzl rare malign perform largest publish date singl center retrospect analysi patient breast emzl focus clinic characterist treatment relat outcom rariti diseas center concord preval report literatur breast emzl compris mzl case patient present stage ii diseas howev four patient stage iv diseas most due occult bone marrow bm involv interest emzl frequent non fdg avid stage petct median follow year rang month year year progress free surviv ci overal surviv ci patient experienc higher grade transform herein show local breast emzl effect treat radiat therapi provid long term diseas control | D018442;D000072078 | T191;T060 |
34,672,246 | cytoplasm cda promis biomark b lymphoblast leukemia follow post cd car therapi minim residu diseas mrd detect import prognost paramet patient refractori relaps b cell acut lymphoblast leukemia rr b cda report exhibit high degre linag specif b cell differenti specif sensit studi investig effici prognost role cytoplasm cda ccda antibodi gate multicolor flow cytometri mfc mrd detect patient b receiv cd target chimer antigen receptor car cell therapi bridg allogen hematopoiet stem cell transplant allo hsct retrospect analysi carri patient accept allo hsct cd car infus june may mfc mrd status allo hsct strong correl transplant prognosi mfc panel ccda gate effect monitor mrd cd car cell therapi predict prognosi allo hsct trial registr clinicaltri chictr iih gov nct regist may retrospect regist https wwwclinicaltrialsgov | D018380;D054198;D000076962 | T191;T116;T129;T192;T061 |
34,672,245 | improv surviv allogen transplant acut lymphoblast leukemia adult danish popul base studi investig trend surviv popul base cohort studi adult receiv hct denmark patient median min max age year hct follow median eight year overal surviv os improv time estim year os ci year versus ci year patient achiev cure time cure per year ci rate death non cure patient remain stabl hr excess mortal per year ci relaps decreas time hr per year ci wherea non relaps mortal chang notabl hr per year ci conclus surviv hct adult improv past two decad primarili due patient achiev cure | D018380;D054198 | T191;T061 |
34,672,244 | smolder multipl myeloma biolog clinic manifest manag smolder multipl myeloma smm heterogen group asymptomat plasma cell disord character presenc monoclon protein gl andor bone marrow plasma cell evid slim crab criteria accord intern myeloma work group imwg recommend effort reclassifi smm activ diseas mm requir treatment complet need redefin new high risk smm aros imwg risk model add high risk cytogenet abnorm allow identifi high risk smm risk progress mm within year therefor might help propos better therapeut approach either goal cure profound debulk mm aggress therapi altern restor immun surveil like delay strategi immun base therapi debat still ongo clear challeng watch wait standard care | D009101;D000075122 | T191 |
34,672,242 | love time anti black social rank attach race psychotherapi paper draw critic race theori research attach social rank dehuman theoriz implic address anti black psychotherapi black non black client context white supremaci draw critiqu recent review attach theori race author draw histor empir research outlin contour racial capitalist world recontextu attach theori critic race theori len argu psychotherapi must address anti black black non black client redefin therapeut action provis repair interperson ruptur also capac mental socio histor ruptur allow space clarifi pursu one valu despit anti black capitalist white supremacist world paper provid case exampl illustr principl black non black client conclud clinic polit implic | D008149;D009769 | T080;T041 |
34,672,241 | inferior outcom r ceop patient diffus larg b cell lymphoma cardiovascular comorbid anthracyclin base chemoimmunotherapi r chop standard treatment diffus larg b cell lymphoma dlbcl associ increas risk cardiotox altern regimen r ceop substitut etoposid doxorubicin common administ dlbcl patient cardiovascular comorbid although limit evid support use multicent real world studi includ consecut patient newli diagnos dlbcl treat r ceop patient treat r chop match age intern prognost index median follow time year r ceop associ signific inferior year progress free surviv vs p overal surviv vs p diseas specif surviv vs p compar r chop r chop remain prefer regimen patient dlbcl r ceop may reason choic patient strict inelig anthracyclin inferior outcom regimen suggest high risk popul requir novel therapeut approach | D016403 | T191 |
34,672,238 | government public themat pattern vaccin measl outbreak romanian perspect confirm case measl romania septemb ministri health launch onlin campaign call vaccin save live studi seek appli health belief model hbm construct onlin communic among romanian ministri health onlin user throughout vaccin campaign use mix method approach demonstr cluster analysi help visual overal relationship among code hbm construct themat interpret relat vaccin result cluster analysi show romanian ministri health use three main theme shape credibl realiti versus conspiraci unbias inform focus diseas vaccin could prevent romanian author also address issu relat conspiraci theori possibl side effect collater victim parent refus vaccin children onlin user comment structur two theme multi facet reluct vaccin gain despit anti vaccin comment anti work relat content direct toward campaign ministri health pro vaccin comment onlin user encourag parent report case side effect accus use person stori provok vaccin hesit find may provid import inform inter nation communic practition design implement health campaign increas vaccin rate | D008457 | T047 |
34,672,236 | technolog enhanc weight loss program multipl cat household random control trial object studi determin whether technolog enhanc weight loss program use home pet health technolog ecosystem effect tool felin weight loss manag multipl cat household evalu impact cat behavior | D061217 | T058 |
34,672,233 | mechanist investig antifung antiaflatoxigen activ chemic characteris carum carvi l essenti oil fungal infest aflatoxin contamin herbal raw materi studi aim investig effici chemic characteris carum carvi essenti oil cceo aflatoxin b afb produc strain aspergillus flavus af lhp ws caus deterior herbal raw materi hrm gc ms analysi eo reveal presenc carvon domin compon cceo caus complet suppress flavus growth afb secret lml respect investig antifung mode action show cceo inhibit fungal growth via abrog ergosterol biosynthesi trigger efflux vital cellular ion inhibit afb biosynthesi attribut inhibit cellular methylglyox mg biosynthesi addit cceo show remark antioxid activ ic lml dpph diphenyl picrylhydrazyl radic base overal result conclud cceo may recommend potenti antifung agent protect hrm fungal infest afb contamin | D000348;D029974;D009822 | T131;T002;T109 |
34,672,232 | vitro activ essenti oil microbi isol otiti externa case dog despit number studi focus potenti use essenti oil eo altern convent treatment canin extern otiti controversi antimicrobi activ could explain differ technic biolog aspect studi focus antimicrobi activ three singl eo compound thymol cinnamaldehyd carvacrol two eo clove oregano clinic isol recov canin otiti externa case bacteri isol belong five differ genera six malassezia pachydermati isol compound show activ cinnamaldehyd exhibit highest bactericid fungicid activ suscept lower among bacteri isol fungal isol differ evid gram posit bacteria relationship antibiot multi resist profil suscept compound observ sum result provid appropri inform appropri concentr promis candid topic treatment canin otiti | D004283;D009822;D010032 | T047;T109 |
34,672,230 | tradit herbal medicin sipjeondaebo tang cancer relat fatigu random placebo control preliminari studi sipjeondaebo tang sdt wide use tradit herbal medicin reliev fatigu random placebo control preliminari studi evalu sdt cancer relat fatigu common symptom experienc patient cancer | D004365;D009369 | T191;T121;T123 |
34,672,228 | person effect sar cov pandem japan toughest triag japan healthcar system consid one world finest howev medic facil across japan struggl cope recent surg novel coronavirus infect leav medic care system mani area brink collaps physician burnout alreadi grow problem coronavirus diseas pandem made wors person impact coronavirus diseas japan report | D000086382;D058873 | T047;T067 |
34,672,227 | investig inject gold nanoparticl extracellular matrix post traumat osteoarthr ptoa progress articular degen diseas degrad articular cartilag stimul apoptosi chondrocyt cell inject decellular extracellular matrix ecm scaffold might abl combat effect ptoa develop ecm conjug nm gold nanoparticl aunp supplement curcumin hyaluron acid ha porcin diaphragm ecm decellular homogen aunp conjug use chemic crosslink follow mix curcumin andor ha inject forc test scan electron microscopi energi dispers x ray spectroscopi util character ecm scaffold vitro test l murin fibroblast equin synovi fibroblast human chondrocyt use determin biocompat reactiv oxygen speci ros reduct chondroprotect abil result demonstr conjug nm aunp ecm success without signific alter physic properti note low inject forc vitro work provid evid biocompat propens reduc intracellular ros abil mitig apoptosi chondrocyt cell stimul il known apoptosi induc cytokin conclud inject aunp ecm may abil mitig inflamm apoptosi | D002358;D053768 | T024;T073 |
34,672,226 | develop test algorithm prevent medic devic relat pressur injuri develop test effect algorithm prevent medic devic relat pressur injuri intens care unit patient develop four stage literatur review analysi medic record preliminari algorithm develop valid preliminari algorithm expert two round practic feasibl verif revis algorithm intens care unit nurs verifi algorithm effect compar incid medic devic relat pressur injuri patient without algorithm applic control group patient algorithm applic experiment group outcom skin inspect medic devic attach pressur injuri evalu implement pressur injuri prevent nurs care base medic devic type incid rate per devic control group per devic experiment group sinc homogen previous score braden scale experiment control group result regard incid pressur damag appli algorithm interpret care appli algorithm safe intervent help prevent medic devic relat pressur injuri popul | D003668 | T047 |
34,672,225 | carvon quorum sens inhibitor block biofilm format chromobacterium violaceum carvon natur monoterpenoid studi test role attenu quorum sens qs control biofilm format chromobacterium violaceum show signific qs inhibit term reduct violacein concentr rang gml c violaceum atcc concentr carvon also inhibit biofilm format biofilm morpholog c violaceum uniqu well organis pattern cell arrang tight matrix evid scan electron microscopi howev carvon treatment show reduct biofilm densiti also disrupt biofilm matrix interrupt biofilm format attribut reduct exopolysaccharid product swarm motil molecular investig rt pcr show import gene involv biofilm regul pil pil r pil b pil downregul signific treatment group | D002861;D053038 | T043;T007 |
34,672,224 | match adjust indirect comparison pneumococc vaccin v pcv v valent pneumococc conjug vaccin pcv valent pcv pcv approv adult year unit state present methodolog indirect compar immun respons v versus pcv | D011008;D022242 | T129;T047;T121 |
34,672,223 | heparin function cover stent prepar plasma technolog studi surfac cover stent treat plasma technolog introduc amino function group glutaraldehyd heparin success graft prepar heparin function cover stent hplcs prepar paramet plasma treatment power plasma treatment time concentr glutaraldehyd heparin ph heparin solut studi detail function heparin cover stent make titer heparin reach iucm anim experi implant pig month titer heparin still reach iucm work provid good method prepar heparin cover stent | D006493;D015607 | T074;T121;T109;T123 |
34,672,220 | multiplex protein analysi studi glaucoma glaucoma lead caus irrevers blind world chronic neurodegen diseas multifactori origin extens research ongo better understand prevent treat progress degener retin ganglion cell glaucoma experiment model glaucoma postmortem tissu human donor analyz pathophysiolog comprehens improv treatment blind diseas clinic sampl intraocular biofluid blood collect glaucoma patient analyz identifi predict diagnost prognost biomark multiplex techniqu protein analysi offer valuabl approach translat glaucoma research | D005901;D019636 | T047 |
34,672,219 | assist periton dialysi across europ practic variat factor associ avail europ number elder end stage kidney diseas patient increas patient receiv periton dialysi pd mani perform pd autonom assist pd programm avail european countri percentag patient receiv assist pd vari consider henc assess factor associ avail assist pd programm centr level whether avail programm associ proport home dialysi patient | D007676;D009398;D010530 | T091;T047;T061 |
34,672,217 | associ circul common uncommon polyunsatur fatti acid modif effect dietari qualiti caus diseas specif mortal nhane associ dietari supplementari intak sever unsatur fatti acid mortal wide studi result still hitherto inconsist limit still need explor effect fatti acid use object biomark | D009026 | T081 |
34,672,215 | relationship symptom sever caregiv burden cancer patient palliat care cross section studi hospit stress experi primari caregiv pcs cancer patient alik although signific evid pcs cancer patient experi signific caregiv burden cb less known relationship pcs patient symptom sever influenc cb method cross section studi measur symptom sever obtain cancer patient pcs assess cb associ patient symptom demograph characterist cb investig use multivari analys result total particip patient caregiv dyad fill questionnair accord zarit burden interview result pcs high cb pain tired nausea depress drowsi well dyspnea signific higher mean valu high cb p financi difficulti first degre relationship patient higher anxieti level pronounc tired appear variabl predict high cb conclus conclus present studi show cb pcs among group hospit incur cancer patient pcs symptomat cancer patient higher cb accord find emphas signific palliat care appropri guidanc provid psychostress caus cb | D009369;D010166 | T191;T061 |
34,672,214 | drug induc pulmonari toxic breast cancer patient treat system therapi systemat literatur review drug induc pulmonari toxic dipt associ breast cancer bc therapi major concern recent time dipt may attribut singl type therapi concomit use anticanc drug along radiotherapi independ risk factor pulmonari toxic | D000970;D001943;D008171;D004364 | T191;T047;T121;T109 |
34,672,213 | kommerel diverticulum retroesophag aberr brachiocephal arteri right aortic arch adult retroesophag aberr brachiocephal arteri rare congenit aortic arch anomali herein present year old man right aortic arch retroesophag aberr left brachiocephal arteri left ligamentum arteriosus absent left intern carotid arteri graft replac descend aorta anatom reconstruct left brachiocephal arteri success perform use midlin sternotomi approach without blood transfus discuss surgic manag kommerel diverticulum | D004240;D006330 | T190;T047;T019 |
34,672,212 | cost util analysi singl nucleotid polymorph panel base machin learn algorithm predict risk opioid use disord aim conduct cost util analysi novel genet diagnost test oudtest risk develop opioid use disord elect orthoped surgeri patient materi method simul model assess cost effect qualiti adjust life year qali oudtest privat insur self insur employ perspect year time horizon hypothet patient popul result oudtest found cost less increas qali year period privat insur save us qali self insur employ us qali oudtest domin strategi privat insur self insur employ model iter sensit analys reveal robust result except physician complianc conclus oudtest expect cost effect solut person postsurg pain manag orthoped patient | D009293;D020641 | T086;T048 |
34,672,211 | religi transit among babi boomer young adulthood later life associ psycholog well year use classif analysi examin chang religios among babi boomer young adulthood earli old age religios transit pattern associ psycholog well later life addit test gender differ associ appli latent class latent transit analysi babi boomer particip longitudin studi generat wave wave identifi three class describ religios wave strong religi doctrin religi weak religi consid five type chang stabil religi class membership wave wave multipl regress gender interact reveal men stay strong religi period report better psycholog well compar men declin religios pattern found women find suggest maintain strong religios life cours benefici babi boom men later life | D008137 | T062;T170;T081 |
34,672,210 | antibacteri data synthesi challeng systemat review treatment complic gram negat urinari tract infect aim determin suitabl network meta analysi nma use antibacteri treatment evid complic urinari tract infect materi method conduct systemat literatur review identifi publish clinic trial data complic urinari tract infect treatment perform feasibl assess determin whether avail evid would support creation robust nma consid key assumpt homogen similar consist result twenti five trial met elig criteria risk bias low individu studi met primari end point assumpt central conduct robust nma met heterogen ubiquit includ baselin pathogen treatment patient characterist conclus limit heterogen data identifi make use nma compar novel antibacteri agent impract like unreli | D014552 | T047 |
34,672,209 | gerontolog inquiri religios spiritu rememb forgotten variabl studi age human develop submiss introduct complement special issu forgotten variabl religios spiritu inquiri | D005853;D029181 | T091;T090;T078 |
34,672,207 | green diabet summit juli diabet technolog societi conven virtual green diabet summit event consist repres key stakehold group base unit state europ purpos summit provid background complex address sustain relat issu includ wast manag diabet devic mani differ perspect along product life cycl stage determin feasibl role coalit stakehold find solut particular design use proper dispos diabet devic use home care one stakehold resolv | D003920;D018505 | T047;T068 |
34,672,206 | latest develop area therapeut deliveri exclud diseas covid big three hivaid malaria tuberculosi begin new decad covid big three hivaid malaria tuberculosi rais public awar type challeng research face everi day beyond diseas also still mani scientist work develop new therapi impact healthcar enorm industri updat cover period august exampl research approv mani diseas exclud covid big three present progress trend approv novel drug candid propos new indic exist one patent relat rare diseas also publish month inform analys sourc scientif literatur regulatori patent agenc websit press releas compani base upon person opinion main reason leav covid research outsid scope updat main due rapid growth chang field preliminari result requir research scientist must awar final impact research could public opinion moreov result disrupt health care face covid sever research group simpli stop research diseas reason imper sum import advanc critic diseas health area | D000086382;D008288;D004364;D014376 | T047;T121;T067 |
34,672,205 | situat nurs hospit second wave covid pandem onlin survey situat nurs hospit second wave covid pandem onlin survey abstract background covid pandem impact stress wellb nurs anxieti infect lack protect equip insuffici expertis care patient describ reason burnout aim influenc work relat sens coher well perceiv organiz support burnout level intent leav job explor method decemb januari staff hospit hessia germani invit particip onlin survey use bat burnout assess tool work soc work relat senc coher pos perceiv organiz support short version item base literatur review result nurs show moder high burnout level want leav job pandem higher work soc p higher pos p lower burnout level train organ mention nurs posit factor miss support mind resili train child care health relat topic agre employ everyth support conclus regardless pandem salutogen leadership requir deal moral injuri employe result implicit ration foster health relat support | D002055;D000086382 | T048;T047;T067 |
34,672,204 | integr person medicin health system progress path forward tweetabl abstract fuel technolog advanc integr effort mani pioneer health system person medicin clinic implement measur incomplet level system wide | D057285 | T091;T061 |
34,672,202 | consid relev childhood religi experi centenarian oral histori current studi explor sub sampl narrat focus childhood religi experi oklahoma oral histori project analys identifi three primari theme connect childhood religios includ transmiss access social first transmiss religios childhood depend upon parent grandpar second theme involv access highlight various advantag disadvantag regard child famili abil attend religi servic opportun barrier center upon three subthem involv rural transport infrastructur final social repres third theme particular church attend childhood creat uniqu opportun earli life social famili friend neighbor whole key theme indic religios childhood may vital earli format social opportun connect may support posit adapt development process human longev find implic relat advanc conceptu understand impact childhood religi experi development outcom among long live adult | D000087662;D012067 | T100;T078 |
34,672,201 | effect week pilat train program cardiac autonom modul random control clinic trial aim evalu effect week pilat train program cardiac autonom modul materi method random control trial week pilat train program conduct total men random alloc either control pilat group initi rr interv captur min later analysi heart rate variabl hrv train protocol initi pilat group perform session pilat method approxim min session three time week total week control group instruct maintain normal activ period one week end train final evalu perform captur rr interv group linear indic time sdnn rmssd frequenc low frequenc lf high frequenc hf domain poincar plot sd sd use nonlinear indic also analyz approxim entropi detrend fluctuat analysi descript statist general mix model perform result group effect lf ms time effect sd train effect observ time group interact increas global hrv indic found pilat group week sdnn mean differ md standard deviat sd es lf ms md sd es sd md sd es conclus week pilat train program promot signific improv global modul hrv pilat group consid signific increas sdnn lf ms sd indic trial registr number nct | D001341;D026241 | T022;T061 |
34,672,196 | programm print paper base devic mos np gmpeu cit fluoresc coupl ratiometr tetracyclin analysi various natur sampl paper base fluoresc devic smartphon aid bring consider oper conveni tetracyclin tc sens nevertheless must meet challeng real determin complic background consid present programm print paper base devic appli tc determin various natur sampl mos nps gmpeu cit synthet composit probe static quench process found mos np fluoresc nm signific magnif gmpeu cit emiss obtain nm establish valuabl ratiometr indic remark two stage programm print maxim propos sens capabl transit devic contain gradual chang amount certain probe prepar sens tc homemad smartphon applic print measur chamber correspond signal examin explor optim setup setup automat process prepar final version devic requir manual oper benefit interest featur propos devic gain mani reward perform effect sens tc wide rang nm simultan provid nake eye legibl signal smartphon base readout confid select stabil devic consequ appli various sampl soil river water milk serum meet well hplc ms recoveri test | D005063;D008982 | T196;T123 |
34,672,194 | ellag acid exert benefici effect hyperuricemia inhibit xanthin oxidas nlrp inflammasom activ hyperuricemia metabol diseas caus impair uric acid ua metabol ellag acid ea natur small molecul polyphenol compound known antioxid anti inflammatori properti evalu regulatori effect ea hyperuricemia explor under mechan found ea effect xanthin oxidas xod inhibitor ic moll superoxid anion scaveng ic moll ea moll treatment signific dose depend reduc ua level l cell meanwhil intraperiton ea administr mgkg also signific reduc serum xod activ ua level hyperuricem mice mark improv liver kidney histopatholog ea treatment signific reduc degre foot edema inhibit express nlpr pathway relat protein foot tissu monosodium urat msu treat mice anti inflammatori effect also observ lipopolysaccharid stimul raw cell furthermor ea signific inhibit express xod nlrp pathway relat protein tlr p p caspas tnf il vitro vivo result indic ea exert amelior effect experiment hyperuricemia foot edema via regul nlrp signal pathway repres promis therapeut option manag hyperuricemia | D033461 | T047 |
34,672,186 | advantag disadvantag use carbon nanostructur reproduct medicin two side coin carbon nanostructur import nanomateri interest physic chemic properti nanostructur assess applic differ field medicin cancer detect treatment parkinson diseas reproduct medicin etc nanomateri use reproduct medicin drug deliveri system antifung antivir antibacteri agent condom coat agent enhanc sperm fertil abil ectop pregnanc treatment trophoblast diseas endometriosi uterin fibroid assist reproduct techniqu art improv side coin involv various side effect carbon nanostructur especi negat effect reproduct system carbon nanostructur show toxic reproduct system produc reactiv oxygen speci oxid stress less attent given uniqu properti carbon nanostructur except practic attract side coin name risk side effect compound especi case reproduct system support surviv health futur generat therefor suggest pay particular attent negat aspect increas use carbon nanostructur | D049329;D018456 | T091;T073 |
34,672,185 | action attitud immun patient sar cov access covid vaccin million human be high level protect diseas mild sever form togeth plausibl decreas transmiss infect vaccin patient prompt seri question member colleg physician madrid icomem societi icomem scientif committe subject tri answer question discuss consensus among member main answer summar follow occurr new sar cov infect vaccin previous infect patient low observ time alreadi breakthrough infect occur usual asymptomat mild purport lower capac transmiss person vaccin subject contact sar cov infect patient avoid quarantin long asymptomat although decis depend variabl age occup circul variant degre contact time sinc vaccin countri high proport popul vaccin alreadi suggest fulli vaccin person could avoid use mask social distanc circumst systemat use diagnost test assess immun respons degre protect reinfect natur infect vaccin discourag sinc practic consequ known time exist inform preclud precis regard possibl need futur revaccin committe consid mass vaccin health care worker general popul achiev sar cov screen test could avoid least outpati care case exploratori procedur requir hospit | D000086382;D000086402 | T047;T005;T067 |
34,672,184 | spatio tempor model tick life stage count data spatial vari coeffici vast amount geo referenc data mani field studi includ ecolog studi geo referenc usual point referenc latitud longitud areal referenc includ district counti state provinc administr unit avail larg geo referenc dataset model necessit develop applic spatial statist method howev spatial vari coeffici model explor abund tick count remain limit studi use data collect prepar research depart biolog scienc old dominion univers virginia usa model tick life stage count abund variabl sampl locat differ habitat number three habitat type name wood edg grass collect month may decemb spatio tempor poisson spatio tempor negat binomi nb count data model fit data compar use devianc inform criteria dic nb model outperform poisson model dic valu smaller poisson model result show covari vari spatial across counti decreas time year effect studi period howev even though time effect decreas studi period space time interact effect seen increas time york counti | D013987 | T204 |
34,672,183 | spatial comparison herald main wave london nineteenth centuri cholera epidem nineteenth centuri london experienc four extraordinarili sever summertim cholera epidem three preced less sever non summer outbreak twenti first centuri research hypothes herald wave potenti new cholera strain studi examin geograph characterist herald wave compar subsequ main wave determin geograph compon signific differ wave sever cholera mortal data london parish registr district extract contemporan record data normal scale epidem wave divid two segment analysi spearman rank correl use assess relationship herald subsequ main wave geospati analyt tool use determin display segment geograph distribut pattern use autocorrel techniqu determin central point result show herald wave epidem share characterist similar follow main wave central point locat similar spearman rank coeffici show high degre correl autocorrel result similar one except reflect appal anomal cholera outbreak institut children demonstr similar epidem herald main wave studi detect spatial characterist could explain observ differ sever studi herald main | D002771;D058872 | T047;T067 |
34,672,182 | use locat alloc p median model optimis locat health care centr citi jeddah citi saudi arabia consid spatial access health servic critic part plan manag health servic evid poor geograph locat obstruct prompt basic health care servic popul section develop locat alloc p median model health centr analys site demand locat health servic road network jeddah saudi arabia model attempt optim health care servic network put forward locat recommend maximis servic coverag model shown use provid robust evid base urban planner policymak respons make spatial decis develop health sector besid follow paradigm new urban encourag decentralis essenti facil includ basic healthcar citi emphasi offer basic servic within walkabl distanc min less | D040362;D006268 | T170;T093;T073 |
34,672,181 | geospati databas manag system collect medicin plant medicin plant increas use medic applic person healthcar howev exist herbal databas system plant retriev offer basic inform support real time analysi spatial aspect plantat distribut site moreov data record usual static public avail reli cost proprietari softwar packag address shortcom includ limit time need collect data process novel medicin plant geospati databas manag system propos system allow local plant site data present interact heat map display spatial inform plant select user within specif radius user locat includ automat present itinerari give optim rout user locat plant destin select approach reli dynam role base data manag interact map includ graphic integr geospati analys thank cross platform geograph javascript librari googl api spatial data attribut avail real time system would support effect collabor among herb farmer govern agenc privat investor healthcar profession general public regard various aspect medicin plant applic | D010946 | T002 |
34,672,180 | spatial access health care servic among children cerebr palsi johor peninsular malaysia cerebr palsi cp one common caus disabl childhood lead function limit poor nutrit status famili cp children face challeng provid proper care thus access cp patient health facil import ensur maintain regular visit health facil proper treatment care current studi aim map spatial distribut cp johor malaysia measur access cp patient nearbi hospit health clinic communiti base rehabilit centr studi base cp case obtain depart social welfar malaysia analys use averag nearest neighbour buffer analysi kernel densiti estim result indic general good access health care servic mani cp children johor live km away health clinic communiti base rehabilit centr regular visit problem inform use target intervent plan health care strategi furthermor inform hospit access cp children would allow plan proper regular treatment patient studi shown possibl improv understand distribut cp case integr spatial analysi use geograph inform system without reli offici inform densiti popul | D002547 | T047;T019 |
34,672,179 | spatial socioeconom inequ avail communiti health centr jakarta region indonesia late indonesia establish communiti health centr chcs throughout countri provid basic healthcar servic poor howev chc expenditur invest vari wide sub provinci level among administr area known citi regenc rais concern facil servic correspond popul need studi aim examin spatial socioeconom inequ avail chcs jakarta region use spatial statist analysi method villag level investig inequ base chc data ministri health socioeconom data indonesia statist result show chcs healthcar worker within uneven distribut area high need avail chcs healthcar worker found low mismatch healthcar servic deliveri low incom unemploy popul villag level need address find discuss paper suggest jakarta depart health coordin local public health district determin locat new chcs assign healthcar worker chc base need would improv access essenti health servic low incom popul | D003151;D011634 | T091;T093;T073 |
34,672,178 | develop web geograph inform system applic plot tuberculosi case last decad public health surveil increas appli statist method analyz spatial diseas distribut nevertheless contact trace follow control measur tuberculosi tb patient remain challeng public health offic often lack program skill need util softwar appropri studi aim develop user friend applic appli codeignit framework server develop arcgi javascript data display web applic base javascript hypertext preprocessor build server interfac webgi technolog use map perform approach test base tb case sociodemograph data age gender race nation countri origin educ level employ status health care worker status incom status resid status smoke status st januari st decemb gombak selangor malaysia data collect gombak district health offic rawang health clinic latitud longitud locat case geocod upload spatial data use googl earth main output interact map display locat case filter avail select various sociodemograph factor interest applic develop assist public health expert util spatial data surveil purpos comprehens well draft regul aim reduc mortal morbid thus minim public health impact diseas | D040362;D014376 | T047;T170;T073 |
34,672,177 | caecal duplic case report caecum one rarest site intestin duplic cyst common symptomatolog includ vomit abdomin pain abdomin distent palpabl mass rectal bleed duplic diagnos within first two year life includ prenat diagnosi case caecal duplic report literatur present day go present case five year old girl caecum duplic reach ward due abdomin distens symptom | D003560;D004065 | T190;T019 |
34,672,164 | sar cov alcohol consumpt liver injuri angiotensin convert enzym ace receptor site sever acut respiratori syndrom coronavirus sar cov respons diseas call covid present liver especi correspond cholangiocyt liver damag sar cov infect due sever mechan includ direct cytopath effect synergi intestin damageliv damag lipopolysaccharideskupf cell interact uncontrol immun reaction lymphopenia signific increas c reactiv protein ferritin lactat dehydrogenas dimer interleukin il il il interferon gamma etc sepsi drug induc liver injuri hypoxia thromboembol event increas aspart aminotransferas ast alanin transaminas alt report mean level ast alt report higher patient admit intens care unit hospit ordinari hospit unit correl liver damag wors prognosi known fact confirm numer studi pandem phase consumpt alcohol reduc innat acquir immun activ hypothes habit correl liver increas ace receptor furthermor nonalcohol alcohol steatosissteatohepat breed ground develop oxid stress context encount sar cov infect support aggrav system cytokin tsunami | D000086382;D008107 | T033;T047;T067 |
34,672,161 | preliminari report investig use mask cardiopulmonari exercis test chines children may result misinterpret misdiagnosi object observ increas anatom dead space mask summar law exercis induc oscillatori breath eiob result cpet new figur analyz incid age group prone oscillatori breath method sign inform consent form guardian children pre school middl school age year perform harbor ucla standard protocol cpet strict qualiti control cpet laboratori liaocheng children hospit sinc cpet data interpret second second breath breath collect averag display plot analyz trend pattern incid age differ eiob gas leakag result incid eiob highest year old group year old group year old group three group test chi squar x differ statist signific p children air leakag cpet incid rate conclus phenomenon oscillatori breath ob children may caus increas anatom dead space mask caus diseas improv qualiti cpet reduc clinic misdiagnosi recommend use mouthpiec decreas dead space rather musk | D005080;D012119 | T039;T060 |
34,672,160 | new theori cpet guid overal plan individu precis exercis effect improv overal function status frailti object guidanc new theori holist integr physiolog medicin effect individu accur exercis program overal function state studi accord cardiopulmonari exercis test cpet method li xx femal year old fast heart rate sinc childhood bpm usual feel cold especi autumn winter general health good cpet perform sign inform consent form fuwai hospit septemb peak oxygen uptak anaerob threshold peak cardiac output pred respect oxygen uptak ventil effici carbon dioxid exhaust ventil effici basic normal pred rest heart rate fast blood pressur low blood pressur respons weak exercis heart rate main increas holist integr physiolog medic theori point weak health heart weak main manifest cpet use guid individu precis exercis intens titrat combin continu beat beat blood pressur ecg puls blood glucos dynam monitor formul holisticplan individu quantit exercis reexamin cpet week strengthen manag result week intens holist manag limb warm cold symptom disappear examin cpet peak oxygen uptak peak cardiac output pred increas respect holist weak function status signific improv basic normal oxygen uptak ventil effici carbon dioxid exhaust ventil effici also increas respect rest heart rate blood pressur basic return normal blood pressur heart rate respons exercis normal continu ambulatori blood glucos monitor indic averag blood glucos level decreas slight becam stabl repeat measur result continu ecg beat beat blood pressur also indic decreas heart rate increas blood pressur rest exercis sleep radial puls wave amplitud dicrot wave increas becom pronounc conclus new theoret system guid cpet formul holist plan individu precis exercis safe effect enhanc myocardi contractil increas stroke volum increas blood pressur lower heart rate stabil slight lower blood glucos improv holist function status | D005080;D010101 | T060;T201 |
34,672,159 | effect cardiac rehabilit protocol center person exercis train improv holist function patient coronari heart diseas percutan coronari intervent object investig effect cardiac rehabilit protocol center person exercis train et improv holist function patient stabl angina percutan coronari intervent pci method patient diagnos stabl angina beij rehabilit hospit june decemb random divid control group n et group n patient receiv pci select pci patient control group treat convent cardiac rehabilit without et patient et group treat et base cardiac rehabilit week cardiopulmonari exercis test cpet paramet echocardiogram minut walk distanc mwd group patient record respect pci week pci week et result patient group finish symptom limit maximum cpet patient et group finish week et safe without complic pci week pci differ paramet includ anaerob threshold peak oxygen uptak peak oxygen puls left ventricular eject fraction lvef mwd control group et groupp week treatment mlmin ml minkg peak oxygen uptak ml minkg peak oxygen puls mlbeat mwd patient et group higher signific patient control group p et group variabl includ mlminml minkg pred peak oxygen uptak mlmin ml minkg pred peak oxygen puls mlbeat mwd patient week et signific higher patient pci treatment p notabl ml minkg peak oxygen uptak ml minkg patient et group signific higher week et program compar patient week pci p control group atmlminand peak oxygen pulsemlbeatof patient week treatment higher patient pci p conclus person exercis train pci could improv cardiac function exercis endur et base cardiac rehabilit import part secondari prevent patient pci need wide promot | D000072038;D003327;D062645 | T047;T061 |
34,672,158 | cardiopulmonari exercis test accur prognos risk postop complic patient undergo lung resect good function status object explor valu predict accur risk complic thoracoscop lung resect preoper cpet index method select patient complet cpet static pulmonari function test pft oper follow discharg oper divid group accord presenc absenc complic case complic case complic includ death calcul peak oxygen uptak peak vo core indic compar similar differ patient without complic calcul best cut valu odd ratio result studi male femal age year old case smoke case lymph node metastasi case hypertens case diabet peak vo peak wr respect pred pred fvc vc fev fvc respect pred pred pred signific differ p gender age smoke histori lymph node metastasi core indic peak vo pred peak wr pred fvc vc rest sbp peak sbp also differ p peak vo ml minkg peak vo hr pred vevco slope vco peak hr bmp rer fev fast blood glucos differ indic respect p cut point rest sbp mmhg fev pred peak vo pred peak sbp mmhg peak vo ml minkg vevco slope respect p conclus patient undergo thoracoscop lung resect good function preoper cpet core indic accur predict risk postop complic worthi depth studi | D005080;D000085542 | T033;T060 |
34,672,157 | cardiopulmonari exercis test use evalu object quantit holist function patient neoadjuv chemotherapi object cardiopulmonari exercis test cpet use evalu object quantit holist function patient accept preoper chemotherapi method studi investig reliabl object quantit assess method symptom limit maxim increment cpet chemotherapi patient esophag cancer analyz chang cardiopulmonari metabol function physiolog paramet cpet result patient accept preoper chemotherapi peak oxygen consumpt peak vo p anaerob threshold peak oxygen puls peak pauls oxygen uptak effici plateau ouep decreas p lowest ventilatori equival carbon dioxid slope ventilatori equival carbon dioxid increas p individu patient except one patient peak vo ouep slight increas indic reduc remain patient lowest ventilatori equival carbon dioxid slope ventilatori equival carbon dioxid increas patient except one patient slope ventilatori equival carbon dioxid decreas slight heart rate patient show upward trend state statist differ three patient blood pressur measur patient signific decreas diastol blood pressur p except extrem stateth patient lower oxygen uptak p extrem state p chemotherapi oxygen uptak effici warm state p state p chemotherapi lower chemotherapi ventil equival carbon dioxid chemotherapi state present upward trend ventil equival carbon dioxid warm state p p statist signific oxygen puls four state show decreas trend p show signific decreaseaft chemotherapi petco warm state chemotherapi lower chemotherapi p peto quiescent state warm state extrem state chemotherapi higher chemotherapi nosignific differ conclus holist function capac patient esophag signific decreas day chemotherapi circulatori functionalandentil function paramet signific decreas chemotherapi | D005080;D020360 | T061;T060 |
34,672,156 | individu analysi puls wave shape singl accur power exercis patient long term chronic diseas object observ studi rest radial arteri puls wave chang singl individu exercis patient long term chronic diseas method select patient chronic diseas diseas durat year clear diagnos hypertens andor diabet andor hyperlipemia first complet symptom restrict limit cardiopulmonari exercis test cpet singl individu exercis power exercis intens complet within one week cpet measur record puls wave data exercis min min min exercis obtain puls wave characterist point start point b main wave peak point p trough repuls point pl crest repuls point p end point e raw data abscissa time ordin amplitud correspond point deriv instrument treat end point e previous puls wave start point b next wave return tb zero got main observ indic yb yp ypl yp tp tpl tp te calcul yp ypl yp te tpl te tpl tpl puls rate yp ypl tp tpl secondari observ indic calcul occurr rate dicrot wave obvious crest final analyz individu puls wave data patient exercis averag data overal analysi result patient long term chronic diseas male femal age year old height cm bodi weight kg yb yp ypl yp tp tpl tp te yp ypl yp te tpl te tpl tpl puls rate yp ypl tp tpl min exercis yb ypl yp tpl te decreas yp increas ypl te tpl te tpl tpl decreas yp puls rate yp ypl tp tpl increas p chang trend puls wave min min exercis consist min exercis indic gradual recov rest level exercis min appear rate dicrot wave obvious crest patient long term chronic diseas rest appear rate min min min exercis signific increas p patient incid dicrot wave obvious peak exercis signific increas could continu minut patient incid increas signific minut exercis began decreas minut patient rate appear start increas minut exercis patient incid increas minut exercis decreas patient rate occurr increas briefli minut exercis decreas incid patient drop exercis began rise minut case incid rate increas exercis increas slight minut conclus patient long term chronic diseas radial arteri puls wave short dicrot wave obvious even disappear singl precis power exercis main wave increas posit dicrot wave decreas amplitud increas specif respons analyz individu | D015444;D005080 | T061;T060;T056 |
34,672,155 | relationship characterist durat magnitud oscillatori breath relat exercis function capac patient chronic heart failur object find relationship durat amplitud oscillatori breath ob exercis capac patient chronic heart failur chf studi method two hundr thirti seven chf patient perform maximum increment upright cycl ergometri cardiopulmonari exercis test cpet respiratori gas exchang measur breath breath basi throughout test ob defin continu cycl fluctuat ventil cpet amplitud oscil exceed concurr mean valu chf patient ob ob divid sub group accord peak vo group mild ob peak vo mlminkg group moder ob peak vo mlminkg group sever ob peak vo ml minkg result patient detect ob chf patient among ob patient ob durat relat negat peak vo mlminkg r peak vo pred r vo r relat posit vevco r conclus ob durat relat negat exercis capac chf patient | D015444;D006333 | T061;T047;T056;T046 |
34,672,154 | clinic studi characterist exercis pathophysiolog patient sever heart failur object cardiopulmonari function patient chronic heart failur chf sever limit holist integr exercis pathophysiolog still unclear method sign consent form eighti three patient sever chf octob octob fuwai hospit perform ramp increment load program cardiopulmonari exercis test cpet normal subject serv control cpet perform accord standard harbor ucla mc circulatori respiratori metabol paramet cpet measur analyz result peak oxygen uptak peak vo chf ml minkg pred signific lower control ml minkg pred core paramet cpet anaerob threshold peak oxygen puls oxygen uptak effici platform ouep lowest carbon dioxid output ventil ratio lowest vevco carbon dioxid output ventil slope vevco slope chf signific differ control group p core paramet lung function forc expiratori volum first second fev forc vital capac fvc fev fvc carbon monoxid diffus dlco signific decreas p systol blood pressur stage cpet chf signific lower control group p heart rate peak recoveri stage signific lower control p minut ventil tidal volum respiratori frequenc rest warm signific higher control p tidal volum recoveri signific higher control p vo peak recoveri stage chf signific higher control p oxygen puls peak signific higher control p puls oxygen satur stage cpet chf signific lower control p conclus decreas holist function capac cardiogen chf domin due circulatori limit second due respiratori metabol limit | D015444;D006333 | T061;T047;T056;T046 |
34,672,153 | clinic research report pathophysiolog characterist exercis patient mitral regurgit object cardiopulmonari exercis test cpet use investig exercis pathophysiolog mitral regurgit method patient moder sever mitral regurgit complet standard extrem exercis cpet strict qualiti control sign inform consent sinc normal subject period control group core index cpet analyz calcul accord standard method compar normal subject intergroup statist independ sampl test time patient heart failur exercis oscil breath ob divid two subgroup case without heart failur case heart failur case non ob case ob similar differ compar subgroup result core index cpet peak oxygen uptak pred anaerob threshold pred normal peak oxygen uptak cpet patient mitral regurgit pred peak oxygen puls pred pred oxygen uptak effici plateau pred lowest valu carbon dioxid ventilatori effici pred slope carbon dioxid ventilatori effici pred among oxygen uptak effici plateau ouep normal low index signific abnorm signific differ patient control group p signific differ non ob group ob group signific differ non ob group control group p signific differ non heart failur group heart failur group signific differ non heart failur group control group conclus core index cardiopulmonari exercis signific abnorm patient mitral regurgit signific lower normal subject except low effect oxygen ventil without heart failur ob affect cardiopulmonari function | D008944 | T047 |
34,672,152 | max test verifi clinic research whether individu symptom limit cardiopulmonari exercis test maximum extrem exercis object verifi cardiopulmonari exercis test cpet perform clinic subject maximum extrem exercis design max testmaxdur clinic cpet use max verifi accuraci quantit cpet evalu result whether feasibl safe use specif valu certain index standard stop cpet method two hundr sixteen case fuwai hospit select june januari includ healthi personcontrol group cardiovascular diseasespati group patient cpet peak rer peak heart rate peak blood pressur basic non responsiveth max first attempt subject studi expand cpet end minut break max cycl veloc rmin constant intens equival peak work exhaustedth differ percentag differ peak heart rate peak oxygen uptak calcul percentag differ heart rate oxygen uptak less max defin failur otherwis succes percentag differ max success prove cpet preciseif differ max success prove cpet non extrem exercis result patient group peak vo lmin ml minkg anaerob threshold lmin ml minkg pred peak vo hr mlbeat pred peak rer peak sbp peak wr peak heart rate ouep ratio pred lower control group p vco slope ratio predand lowest vco ratio pred higher patient group control group p advers event occur cpet max case among case max success case cpet prove maximum extrem exercis case non maximum extrem exercis case fail case conclus cpet low peak rer maximum challeng max confirm accuraci object quantit assess cpet max safe feasibl deserv research clinic applic | D005080;D006333 | T047;T060;T046 |
34,672,151 | screen biomark hypertens heart diseas analysi base data medic institut object screen influenc factor hypertens heart diseas hhd establish predict model hhd provid earli warn occurr hhd method select patient diagnos hypertens heart diseas hypertensionfrom januari decemb medic data scienc academi medic school influenc factor screen singl factor multi factor analysi r softwar use construct logist model random forest rf model extrem gradient boost xgboost model result univari analysi screen differ indic multifactor analysi screen differ indic p area curv auc logist model rf model xgboost model respect conclus result three hhd predict model establish paper stabl xgboost predict model good diagnost effect occurr hhd | D006331;D000069550 | T047;T066 |
34,672,150 | preliminari analysi influenc breath heart rate variabl chronic ill patient sleep apnea object base hypothesi respir caus variabl circulatori indic propos holist integr physiolog medicin theori correl respir heart rate variabl sleep chronic ill patient abnorm sleep breath analyz method eleven chronic ill patient abnorm sleep breath apnea hypopnea index ahi timeshr recruit sign inform consent complet standard symptomat restrict extrem exercis cardiopulmonari exercis test cpet sleep breath monitor calcul analyz rule respiratori nasal airflow ecg rr interv heart rate variabl oscillatori breath ob phase normal steadi breath phase patient sleep use independ sampl test compar normal peopl sleep breath abnorm period laboratori patient chronic diseas similar differ result peak oxygen uptak anaerob threshold cpet chronic patient abnorm sleep apnea pred pred case cpet exercis induc oscillatori breath eiob exampl unstabl breath indic overal function status lower normal group patient chronic diseas ahi beatsh ratio total time abnorm sleep breath total time sleep length ob cycl ratio bnhrv b n number breath cycl normal steadi breath period number heart rate variabl cycl group patient chronic diseas cv sd hrv b mx blood oxygen satur spo decreas signific averag amplitud heart rate variabl hrv b respiratori cycl rhythm bpm although lower normal peopl p group patient chronic diseas ratio number respiratori cycl number heart rate variabl cycl ob bnob hrv b n ob averag amplitud heart rate variabl respiratori cycl rhythm ob ob hrv b bpm variabl ob cv sd ob hrv b mx averag amplitud heart rate variabl ob cycl rhythm ob hrv ob bpm spo decreas signific hypoventil ob averag decreas spo ob ob spo ob ob bnob hrv b n ratio ob hrv ob ob spo ob ob period signific higher correspond indic normal stabl breath period larg p variabl ob cv signific increas p conclus heart rate variabl chronic patient abnorm sleep breath ob phase greater normal stabl breath period breath pattern chang heart rate variabl also chang signific number breath cycl stabl breath period equal number heart rate variabl cyclesth ratio normal peopl chronic ill patient without sleep apnea confirm heart rate variabl respiratori origin reduct heart rate variabl relat respiratori cycl ob direct caus hypopnea apnea time heart rate variabl also breath sourc | D012891 | T047 |
34,672,149 | preliminari report variat respiratori heart rate sleep normal subject patient chronic diseas without sleep apnea object new theori holist integr physiolog medicin describ integr regul respiratori circulatori metabol system human bodi generat hypothesi breath origin variabl circulatori paramet investig origin heart rate variabl analyz relationship breath heart rate variabl hrv sleep method retrospect studi analyz normal subject ns patient chronic diseas without sleep apnea cds sa sign inform consent form perform cardiopulmonari exercis test cpet fuwai hospit monitor polysomnographi psg electrocardiogram ecg sleep sinc domin analyz correl respiratori cycl sleep heart rate variabl cycl ecg r r interv hrv cycl includ hr increas lowest highest decreas highest lowest point number hrv hrv n averag hrv time paramet calcul breath cycl includ complet inhal subsequ exhal number breath b n averag breath time breath paramet analyz calcul analyz person relationship breath hrv similar differ ns cds sa group independ sampl test use statist analysi p result cpet core paramet peak vo ns signific higher patient chronic diseas without sleep apnea p averag magnitud hrv ns bpm signific higher cds sa bpm p conclus regardless function status ns cds sa similar consist b hrv origin initi factor hrv respir | D012891 | T047 |
34,672,148 | effect differ work rate increas rate overal function evalu cardiopulmonari exercis test ii sub peak paramet object observ effect healthi volunt differ work rate increas rate cardiopulmonari exercis test cpet sub peak paramet method twelv healthi volunt random assign moder wmin relat low wmin relat high wmin three differ work rate increas rate cpet differ work day week core indic relat cpet sub peak exercis volunt compar accord standard method anaerob threshold oxygen uptak per unit power vo wr oxygen uptak efici plateau ouep lowest averag carbon dioxid ventil equival lowest vco slope carbon dioxid ventil equival vco slope intercept anaerob threshold oxygen uptak ventil effici valu vo anaerob threshold carbon dioxid ventil equival valu vco pair test perform differ paramet three group differ work rate increas rate result compar relat low relat high work rate increas rate group moder work rate increas rate group uptak efici plateau vs vs lowest averag carbon dioxid ventil equival vs vs signific better differ statist signific p compar moder work rate increas rate group oxygen uptak per unit work rate relat low relat high work rate increas rate group increas decreas signific vs vs ml minkg differ statist signific p conclus relat low relat high power increas rate signific chang cpet sub peak sport relat indic effect oxygen uptak ventil effect carbon dioxid exhaust ventil oxygen uptak per unit work rate compar moder work rate increas rate cpet lower higher work rate increas rate signific reduc effect oxygen uptak ventil effect carbon dioxid exhaust ventil healthi individu standard oper cpet requir select work rate increas rate suitabl subject cpet sub peak relat indic best reflect true function state subject | D005080;D010101 | T060;T201 |
34,672,147 | effect differ work rate increas rate overal function evalu cardiopulmonari exercis test peak paramet chang respiratori exchang rate object observ effect healthi volunt differ work rate increas rate cardiopulmonari exercis test cpet peak exercis core indic chang respiratori exchang rate rer exercis explor effect differ work rate increas rate cpet peak exercis relat indic method twelv healthi volunt random assign moder wmin relat low wmin relat high wmin three differ work rate increas rate cpet differ work day week main peak exercis core indic cpet data vo vco work rate wr breath frequenc bf tidal volum vt ventil heart rate hr blood pressur bp oxygen puls p exercis time rer period cpet analyz use standard method anova test pair two two comparison perform differ index three group differ work rate increas rate result compar moder work rate group peak work rate lower higher work rate group relat lower higher respect wmin vs wmin vs wmin p exercis time signific prolong shorten min vs min vs min p peak rer vs vs p p recoveri rer maximum vs vs p p signific decreas increas conclus differ work rate increas rate cpet signific chang peak work rate exercis time peak rer maximum rer recoveri cpet oper choos individu work rate increas rate appropri subject also use fix rer valu basi ensur safeti subject extrem exercis earli termin exercis | D005080;D006333 | T047;T060;T046 |
34,672,146 | deep learn base method accur estim breast tissu optic properti presenc chest wall general imag reconstruct method use diffus optic tomographi dot base diffus approxim consid breast tissu homogen semi infinit medium howev semi infinit medium assumpt use dot reconstruct valid chest wall underneath breast tissu | D000077321;D035441;D041622 | T023;T066;T060 |
34,672,145 | enhanc medic diagnosi doctor perspect optic coher tomographi three decad public ten compani involv commerci global market perspect usd billion optic coher tomographi oct becom one fastest success translat imag techniqu substanti clinic econom impact accept | D009885;D041623 | T091;T060 |
34,672,144 | robot thymectomi surgic point view robot thymectomi innov surgic approach treat diseas anterior mediastinum robot surgeri offer low postop morbid faster recoveri shorter hospit stay better cosmet result without compromis surgic radic oper patient place supin posit left edg oper tabl left hemithorax upward posit maintain sandbag target area autodock toward jugulum first surgic step isol inferior thymic horn via dissect start inferior portion mediastin tissu proceed toward right side follow contralater pleural reflect afterward necessari move toward superior horn follow phrenic nerv first landmark innomin vein second landmark final dissect superior horn search thymic vein could appear atroph clip vessel safe isol innomin vein step use use retract movement progress dissect horn jugulum thymus gland remov en bloc perithymus fat use endoscop bag insert right port incis | D065287;D012371;D013953 | T090;T191;T061 |
34,672,143 | aortic valv neocuspid ozaki procedur aortic valv neocuspid fix autolog pericardium accord ozaki techniqu proven effect therapi treatment aortic valvulopathi various entiti aortic stenosi aortic regurgit aortic valv endocard tricuspid bicuspid aortic valv thus aortic valv neocuspid fix autolog pericardium repres versatil altern complex aortic valv repair better hemodynam compar biolog aortic valv replac without need lifelong anticoagul character mechan aortic valv replac author meticul describ technic step high reproduc standard procedur | D001022;D001024;D001705;D006350 | T074;T047 |
34,672,142 | video assist mediastinoscop lymphadenectomi vamla video vignett mediastin stage potenti resect non small cell lung cancer paramount import sinc impact surviv patient increas nodal stage surviv note precipit declin nodal status also determin use neoadjuvantadjuv therapi treatment modal various method obtain lymphat tissu mediastinum stage purpos describ literatur although mediastinoscop lymph node evalu remain gold standard endoscop method mediastin stage like endobronchi ultrasound guid esophag ultrasound guid fine needl aspir techniqu although minim invas provid highest level accuraci use conjunct surgic mediastin stage video assist mediastinoscop lymphadenectomi vamla provid clear advantag far ergonom train concern convent mediastinoscopi access station r l r l feasibl vamla video vignett present step step techniqu standard vamla overview relev anatom relationship effect safe clearanc lymph node station purpos stage defin appropri therapi | D002289;D008175 | T191 |
34,672,141 | optim set vat right upper lobectomi year old woman multipl ground glass opac largest measur mm biopsi proven primari lung adenocarcinoma right upper lobe perform port right side vat use copenhagen approach pleural effus evid pleural metastat spread tumor identifi upper lobe surround lung tissu appear normal perform multilevel intercost block use levobupivacain inferior pulmonari ligament divid superior pulmonari vein branch pulmonari arteri right upper lobe dissect encircl divid use tan reload endo gia stapler right upper lobe bronchus dissect encircl divid similar fashion use purpl reload endo gia stapler follow success test inflat lower middl lobe horizont fissur complet fire stapler lymph node station sampl sent separ histolog analysi parenchym stump leak cm h test inflat hemostasi pneumostasi check ensur singl fr drain place apex hemostasi complet incis close layer | D000230;D008175 | T191 |
34,672,140 | develop dementia platform databank use multipl exist cohort studi conduct pilot project evalu feasibl build integr dementia platform converg preexist dementia cohort sever variabl level follow four cohort use develop pilot platform clinic research center dementia south korea credo korean brain age studi earli diagnosi predict alzheim diseas k base environment pollut induc neurolog effect epinef studi prospect registri dementia platform korea project dpkr total patient includ platform integr variabl among particip patient normal cognit mild cognit impair dementia respect mean age year femal account patient colleg higher educ without problem read write account respect marit status cohabit famili histori parkinson diseas smoke drink status physic activ sleep status nutrit status rate miss inform although individu cohort domain high qualiti found sever barrier integr individu cohort includ variabl studi variabl measur although mani research tri combin pre exist cohort process integr past data easi therefor necessari establish protocol consider data integr cohort establish stage | D000544;D060825;D003704 | T048;T047 |
34,672,139 | deep learn model high standalon perform diagnosi unruptur intracrani aneurysm studi aim investig whether deep learn model autom detect unruptur intracrani aneurysm time flight tof magnet reson angiographi mra achiev target diagnost perform compar human radiologist approv korean ministri food drug safeti artifici intellig appli softwar | D000077321;D002532 | T190;T047;T066;T046 |
34,672,138 | indocyanin green load plga nanoparticl conjug hyaluron acid improv target specif cervic cancer tumor indocyanin green icg promis agent intraop visual tumor tissu sentinel lymph node earli stage gynecolog cancer howev limit includ short half life poor solubl aqueous solut studi aim enhanc efficaci near infrar nir fluoresc imag overcom shortcom icg use nano drug deliveri system improv target specif cervic cancer | D053758;D002583 | T191;T073 |
34,672,137 | character ferric chlorid induc arteri thrombosi model mice role red blood cell thrombosi acceler ferric chlorid fecl induc thrombosi model wide use thrombosi research howev lack standard uncertainti exact mechan thrombosi studi aim character thrombus format mous model | D013927 | T046 |
34,672,136 | activ cpg odn induc tlr signal inhibit interleukin u human macrophag interleukin il anti inflammatori cytokin inhibit broad spectrum inflammatori respons various human cell includ neutrophil macrophag endotheli cell aim studi identifi role il toll like receptor tlr signal human macrophag | D042783;D051217 | T025;T129;T192;T116 |
34,672,135 | serum clusterin level could reflect current activ antineutrophil cytoplasm antibodi associ vascul investig whether serum clusterin level could reflect current antineutrophil cytoplasm antibodi anca associ vascul aav specif indic | D056648;D019268 | T129;T047;T116 |
34,672,134 | regul muc methyl correl progress gastric cancer studi aim investig mechanist downregul mucin muc influenc progress gastric cancer gc | D013274 | T191 |
34,672,133 | medic risk colorect cancer patient inflammatori bowel diseas use landmark method studi aim determin whether use drug treatment inflammatori bowel diseas relat risk colorect cancer use cox proport hazard model landmark method minim immort time bias | D003093;D015179;D003424;D015212 | T191;T047 |
34,672,132 | transcathet aortic valv replac minim contrast dye patient renal insuffici concern consist rais regard consider amount contrast dye use transcathet aortic valv replac tavr patient renal insuffici present studi introduc minim contrast tavr compar day clinic outcom convent tavr | D001024;D051437;D065467 | T047;T061 |
34,672,131 | sex relat outcom success drug coat balloon treatment de novo coronari arteri diseas although drug coat balloon dcb treatment known effect de novo lesion influenc sex angiograph clinic outcom remain unknown studi aim investig angiograph clinic impact dcb treatment patient de novo coronari lesion accord sex | D003324;D004364 | T047;T121 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.